57237-312-51 : NDC 2026 Code

57237-312-51 : Dextromethorphan Hbr. And Guaifenesin ( Dextromethorphan Hbr. And Guaifenesin )

Additionally :

You can get information about “57237-312-51” NDC code in 57237-312-51 in HTML format

HTML | 57237-312-51 in TXT (Plain Text) format

TXT | 57237-312-51 in PDF (Portable Document Format)

PDF | 57237-312-51 in XML format

XML formats.

NDC Code : 57237-312-51 – JSON Data Format

                
{
  "NDC": {
    "NDCCode": "57237-312-51",
    "PackageDescription": "100 CUP, UNIT-DOSE in 1 BOX, UNIT-DOSE (57237-312-51)  / 5 mL in 1 CUP, UNIT-DOSE (57237-312-05) ",
    "NDC11Code": "57237-0312-51",
    "ProductNDC": "57237-312",
    "ProductTypeName": "HUMAN OTC DRUG",
    "ProprietaryName": "Dextromethorphan Hbr. And Guaifenesin",
    "ProprietaryNameSuffix": null,
    "NonProprietaryName": "Dextromethorphan Hbr. And Guaifenesin",
    "DosageFormName": "SOLUTION",
    "RouteName": "ORAL",
    "StartMarketingDate": "20230612",
    "EndMarketingDate": null,
    "MarketingCategoryName": "OTC MONOGRAPH DRUG",
    "ApplicationNumber": "M012.85",
    "LabelerName": "Rising Pharma Holdings, Inc.",
    "SubstanceName": "DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN",
    "StrengthNumber": "10; 100",
    "StrengthUnit": "mg/5mL; mg/5mL",
    "Pharm_Classes": "Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]",
    "DEASchedule": null,
    "Status": "Active",
    "LastUpdate": "2025-07-09",
    "PackageNdcExcludeFlag": "N",
    "ProductNdcExcludeFlag": "N",
    "ListingRecordCertifiedThrough": "20261231",
    "StartMarketingDatePackage": "20230612",
    "EndMarketingDatePackage": null,
    "SamplePackage": "N"
  }
}